Tempur Sealy International, Inc. (TPX - Free Report) , is involved in the development, manufacturing and marketing of bedding products primarily in North America and internationally. Shares have soared over 80% during the last year to crush its industry’s average and the S&P 500. The mattress powerhouse returned to sales growth in 2018 and its expansion looks poised to continue as it proves it’s ready to fight off challenges from digital upstarts through its own direct-to-consumer expansion and more. Tempur Sealy topped our Q3 earnings and revenues estimates, with adjusted earnings up 28% and sales up 12.5%. Both TPX’s top and bottom line expansions marked the sixth consecutive quarter of growth for the firm.
Delta Air Lines (DAL - Free Report) , is a leading provider of scheduled air transportation for passengers and cargo throughout the United States and around the world. Delta is being aided by a healthy uptick in passenger revenues on the back of strong demand for air travel. Reduction in fuel prices is an added positive. Further, we are upbeat about Delta's efforts to reward its shareholders through dividends and buybacks. Anticipating demand to remain strong, Delta issued a bullish earnings per share projection for 2020. Backed by these tailwinds, shares of Delta outperformed its industry in a year's time.
Treakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Tempur Sealy International, Inc. (TPX - Free Report) , is involved in the development, manufacturing and marketing of bedding products primarily in North America and internationally. Shares have soared over 80% during the last year to crush its industry’s average and the S&P 500. The mattress powerhouse returned to sales growth in 2018 and its expansion looks poised to continue as it proves it’s ready to fight off challenges from digital upstarts through its own direct-to-consumer expansion and more. Tempur Sealy topped our Q3 earnings and revenues estimates, with adjusted earnings up 28% and sales up 12.5%. Both TPX’s top and bottom line expansions marked the sixth consecutive quarter of growth for the firm.
Delta Air Lines (DAL - Free Report) , is a leading provider of scheduled air transportation for passengers and cargo throughout the United States and around the world. Delta is being aided by a healthy uptick in passenger revenues on the back of strong demand for air travel. Reduction in fuel prices is an added positive. Further, we are upbeat about Delta's efforts to reward its shareholders through dividends and buybacks. Anticipating demand to remain strong, Delta issued a bullish earnings per share projection for 2020. Backed by these tailwinds, shares of Delta outperformed its industry in a year's time.
Treakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on DAL - FREE
Get the latest research report on TPX - FREE